Safety and Efficacy of Carvedilol Therapy for Patients with Dilated Cardiomyopathy Secondary to Muscular Dystrophy

被引:0
作者
J. Rhodes
R. Margossian
B. T. Darras
S. D. Colan
K. J. Jenkins
T. Geva
A. J. Powell
机构
[1] Children’s Hospital Boston,Department of Cardiology
[2] Children’s Hospital Boston,Department of Neurology
来源
Pediatric Cardiology | 2008年 / 29卷
关键词
Cardiac magnetic resonance imaging; Carvedilol; Dilated cardiomyopathy; Muscular dystrophy; Ventricular function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:343 / 351
页数:8
相关论文
共 154 条
[1]  
Alfakih K(2003)Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences J Magn Reson Imaging 17 323-329
[2]  
Plein S(2001)Carvedilol as therapy in pediatric heart failure: an intial multicenter experience J Pediatr 138 511-343
[3]  
Thiele H(1997)Dystrophies and heart disease Curr Opin Cardiol 12 329-857
[4]  
Jones T(2005)Effect of peridopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy J Am Coll Cardiol 45 855-1729
[5]  
Ridgway JP(1990)Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure Circulation 82 1724-1765
[6]  
Sivananthan MU(1998)Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Carvedilol N Engl J Med 339 1759-34
[7]  
Bruns LA(2002)Cardiac involvement in progressive muscular dystrophy of the Duchenne type Am J Cardiol 90 29-179
[8]  
Chrisant MK(1997)Cardioprotection for Duchenne’s muscular dystrophy Jpn Heart J 38 163-902
[9]  
Lamour JM(1999)Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy Am Heart J 137 895-2804
[10]  
Shaddy RE(2005)Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy Circulation 112 2799-994